Arrowhead Pharmaceuticals, Inc. (FRA:HDP1)

Arrowhead Pharmaceuticals Statistics

Total Valuation

FRA:HDP1 has a market cap or net worth of EUR 6.57 billion. The enterprise value is 6.45 billion.

Market Cap	6.57B
Enterprise Value	6.45B

Important Dates

The last earnings date was Wednesday, November 26, 2025.

Earnings Date	Nov 26, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	135.81M
Shares Outstanding	n/a
Shares Change (YoY)	+11.67%
Shares Change (QoQ)	-0.84%
Owned by Insiders (%)	3.98%
Owned by Institutions (%)	75.57%
Float	116.79M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	9.30
PB Ratio	15.32
P/TBV Ratio	16.79
P/FCF Ratio	49.14
P/OCF Ratio	42.94
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 53.99, with an EV/FCF ratio of 48.20.

EV / Earnings	-4,636.62
EV / Sales	9.03
EV / EBITDA	53.99
EV / EBIT	76.19
EV / FCF	48.20

Financial Position

The company has a current ratio of 4.86, with a Debt / Equity ratio of 1.46.

Current Ratio	4.86
Quick Ratio	4.73
Debt / Equity	1.46
Debt / EBITDA	5.29
Debt / FCF	4.68
Interest Coverage	1.10

Financial Efficiency

Return on equity (ROE) is 8.67% and return on invested capital (ROIC) is 5.39%.

Return on Equity (ROE)	8.67%
Return on Assets (ROA)	4.87%
Return on Invested Capital (ROIC)	5.39%
Return on Capital Employed (ROCE)	8.27%
Revenue Per Employee	994,288
Profits Per Employee	-1,955
Employee Count	711
Asset Turnover	0.66
Inventory Turnover	n/a

Taxes

In the past 12 months, FRA:HDP1 has paid 18.26 million in taxes.

Income Tax	18.26M
Effective Tax Rate	41.56%

Stock Price Statistics

The stock price has increased by +80.80% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+80.80%
50-Day Moving Average	33.91
200-Day Moving Average	19.81
Relative Strength Index (RSI)	66.26
Average Volume (20 Days)	172

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	4.86

Income Statement

In the last 12 months, FRA:HDP1 had revenue of EUR 706.94 million and -1.39 million in losses. Loss per share was -0.01.

Revenue	706.94M
Gross Profit	706.94M
Operating Income	83.82M
Pretax Income	43.92M
Net Income	-1.39M
EBITDA	104.21M
EBIT	83.82M
Loss Per Share	-0.01

Balance Sheet

The company has 781.96 million in cash and 625.32 million in debt, giving a net cash position of 156.64 million.

Cash & Cash Equivalents	781.96M
Total Debt	625.32M
Net Cash	156.64M
Net Cash Per Share	n/a
Equity (Book Value)	429.06M
Book Value Per Share	2.93
Working Capital	643.62M

Cash Flow

In the last 12 months, operating cash flow was 153.03 million and capital expenditures -19.32 million, giving a free cash flow of 133.71 million.

Operating Cash Flow	153.03M
Capital Expenditures	-19.32M
Free Cash Flow	133.71M
FCF Per Share	n/a

Margins

Gross margin is 100.00%, with operating and profit margins of 11.86% and -0.20%.

Gross Margin	100.00%
Operating Margin	11.86%
Pretax Margin	6.21%
Profit Margin	-0.20%
EBITDA Margin	14.74%
EBIT Margin	11.86%
FCF Margin	18.91%

Dividends & Yields

FRA:HDP1 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.67%
Shareholder Yield	-11.67%
Earnings Yield	-0.02%
FCF Yield	2.03%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 17, 2011. It was a reverse split with a ratio of 0.1.

Last Split Date	Nov 17, 2011
Split Type	Reverse
Split Ratio	0.1

Scores

FRA:HDP1 has an Altman Z-Score of 1.51 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.51
Piotroski F-Score	5